Compare NeoGenomics Inc. Common Stock (NEO) vs Oxford Lane Capital Corp (OXLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NeoGenomics Inc. Common Stock vs Oxford Lane Capital Corp — how do they compare? NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.17B), while Oxford Lane Capital Corp trades at $8.37 (market cap $806.30M). The key difference: NeoGenomics Inc. Common Stock is far larger — about 2.7× Oxford Lane Capital Corp's market cap, and Oxford Lane Capital Corp pays a 29.18% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Oxford Lane Capital Corp for 51 Days on average.
| NEO | OXLC | |
|---|---|---|
Market Cap | $2.17B | $806.30M |
Volume | 1,615,943 | 1,199,574 |
Sector | Health | Financials |
52-Week High | $19.91 | $16.02 |
52-Week Low | $7.19 | $8.15 |
Typical Hold Time | 0 Days | 51 Days |
Enterprise Value | $2.47B | $1.20B |
Dividend Yield | — | 29.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
OXLC trades at $8.34, down 3.02% over the past day, with a bearish technical outlook from moving averages and oscillators. The stock shows a low P/B of 0.78 but negative ROE and ROA, alongside recent earnings misses. Dividends of $0.20 per share are being paid regularly, but cash flow from operations is negative, and 2026 revenue and profit trends are sharply negative. Analyst sentiment is mixed with a 50% buy rating.
The outlook is cautious due to deteriorating fundamentals, including a projected $585M net loss for 2026 and unsustainable dividend payouts relative to earnings. Key risks include high leverage, volatile CLO investments, and potential NAV erosion. Upside may exist if CLO markets stabilize, but current data suggests significant headwinds for shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →About Oxford Lane Capital Corp
Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →
